THALIDOMIDE TREATMENT PREVENTS CHRONIC GRAFT REJECTION AFTER AORTIC TRANSPLANTATION IN RATS

BACKGROUND: Cardiac allograft vasculopathy (CAV) affects approximately 30% of cardiac transplant patients at five years post-transplantation. To date there are few CAV treatment or prevention options, none of which are highly effective. The aim of the study was to investigate the effect of thalidomi...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Transpl Int
Autori principali: Miller, Katharine K., Wang, Dong, Hu, Xiaomeng, Hua, Xiaoqin, Deuse, Tobias, Neofytou, Evgenios, Renne, Thomas, Velden, Joachim, Reichenspurner, Hermann, Schrepfer, Sonja, Bernstein, Daniel
Natura: Artigo
Lingua:Inglês
Pubblicazione: 2017
Soggetti:
Article
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC5643223/
https://ncbi.nlm.nih.gov/pubmed/28672061
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/tri.13004
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi